Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

BACKGROUND: Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic, nonhospitalized patients with Covid-19 who are at high risk for disease progression prevents hospitalization is uncert...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottlieb, Robert L., Vaca, Carlos E., Paredes, Roger, Mera, Jorge, Webb, Brandon J., Perez, Gilberto, Oguchi, Godson, Ryan, Pablo, Nielsen, Bibi U., Brown, Michael, Hidalgo, Ausberto, Sachdeva, Yessica, Mittal, Shilpi, Osiyemi, Olayemi, Skarbinski, Jacek, Juneja, Kavita, Hyland, Robert H., Osinusi, Anu, Chen, Shuguang, Camus, Gregory, Abdelghany, Mazin, Davies, Santosh, Behenna-Renton, Nicole, Duff, Frank, Marty, Francisco M., Katz, Morgan J., Ginde, Adit A., Brown, Samuel M., Schiffer, Joshua T., Hill, Joshua A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757570/
https://www.ncbi.nlm.nih.gov/pubmed/34937145
http://dx.doi.org/10.1056/NEJMoa2116846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757570/
https://www.ncbi.nlm.nih.gov/pubmed/34937145
http://dx.doi.org/10.1056/NEJMoa2116846

Ejemplares similares